Beryl Capital Management LLC - 02 Jan 2025 SCHEDULE 13G Report for Revance Therapeutics, Inc. Common Stock (RVNC)

Filing Manager
Beryl Capital Management LLC
Reporting Manager
Beryl Capital Management LLC
Security
Revance Therapeutics, Inc. Common Stock
Symbol
RVNC
Shares outstanding
104M shares
Disclosed Ownership
6.36M shares
Ownership
6.1%
Form type
SCHEDULE 13G
Filing time
10 Jan 2025, 16:52:46 UTC
Date of event
02 Jan 2025
Next filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Beryl Capital Management LLC 6.1% 6.36M 0 6.36M /s/ Andrew Nelson Chief Operating Officer
Beryl Capital Management LP 6.1% 6.36M 0 6.36M /s/ Andrew Nelson Chief Operating Officer of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP
Beryl Capital Partners II LP 5.3% 5.59M 0 5.59M /s/ Andrew Nelson Chief Operating Officer of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP, General Partner of Beryl Capital Partners II
David A. Witkin 6.1% 6.36M 0 6.36M /s/ David A. Witkin Reporting person